Cancer treatment—hormone therapy start date, DDMMYYYY
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
|---|---|
| Short name: | Hormone therapy start date |
| METEOR identifier: | 561335 |
| Registration status: | Health, Standard 08/05/2014 |
| Definition: | The start date of hormone therapy administered during the course of treatment for cancer, expressed as DDMMYYYY. |
| Data Element Concept: | Cancer treatment—hormone therapy start date |
| Value Domain: | Date DDMMYYYY |
Value domain attributes | ||
Representational attributes | ||
| Representation class: | Date | |
|---|---|---|
| Data type: | Date/Time | |
| Format: | DDMMYYYY | |
| Maximum character length: | 8 | |
Source and reference attributes | |
| Submitting organisation: | Australian Institute of Health and Welfare |
|---|---|
Data element attributes | |
Collection and usage attributes | |
| Guide for use: | Hormone therapy is cancer treatment that achieves its antitumour effect through changes in hormonal balance. This includes the administration of hormones, agents acting via hormonal mechanisms, antihormones and steroids. Record the first or earliest date hormone therapy was administered during the course of treatment. The start date of hormone therapy is recorded regardless of whether the course of treatment is completed as intended, and regardless of the intent or timing of hormone therapy. Do not record the dates for prednisone as hormone therapy when it is administered for reasons other than chemotherapeutic treatment. Only record prednisone as hormone therapy when it is administered in combination with chemotherapy such as MOPP (mechlorethamine, vincristine, procarbazine, prednisone) or COPP (cyclophosphamide, vincristine, procarbazine, prednisone). Tumour involvement or cancer treatment may destroy hormone-producing tissue. Hormone replacement therapy will be given if the hormone is necessary to maintain normal metabolism and body function. Hormone replacement therapy should only be recorded as part of a subsequent course of treatment and not the initial course of treatment. A patient may undergo hormone therapy for an extended period of time. Multiple entries are not permitted. Dates of surgery, radiotherapy and other systemic treatments are collected as separate items. However, if a patient receives treatment with a protocol that includes different types of systemic therapy agents, for example, a chemotherapy agent and a hormone therapy agent, record the start date of treatment in both relevant data items. |
|---|---|
| Collection methods: | The information should be obtained from the patient’s medical record. |
| Comments: | Collecting the start and finish dates for treatment modalities will enable an estimate of treatment duration. |
Source and reference attributes | |
| Submitting organisation: | Cancer Australia |
| Origin: | American College of Surgeons 2002. Facility Oncology Registry Data Standards (FORDS), 2009 revision. Commission on Cancer American College of Surgeons 1998. Standards of the Commission on Cancer: Registry Operations and Data Standards (ROADS), Volume II. Commission on Cancer |
Relational attributes | |
| Related metadata references: | Supersedes Cancer treatment—hormone therapy start date, DDMMYYYY Health, Superseded 08/05/2014 See also Cancer treatment—hormone therapy agent name, systemic therapy agent or protocol name, text X[X(149)] Health, Recorded 17/05/2011 See also Cancer treatment—hormone therapy completion date, DDMMYYYY Health, Standard 08/05/2014 See also Cancer treatment—systemic therapy agent or protocol, text X[X(149)] Health, Standard 08/05/2014 |
| Implementation in Data Set Specifications: | Hormone therapy for cancer cluster Health, Standard 08/05/2014 |